Exploring Circular RNAs: The Challenges and Wonders of RNA’s Unique Structure
Why Circular RNAs Could Be Game-Changing in Medicine
Circular RNAs (circRNAs) have transformed from being dismissed as splicing errors to promising players in the world of biology and medicine. Found across the tree of life, these unique RNA molecules form loops through an atypical splicing process, known as back-splicing. Despite their low abundance—making up only about 0.1% of non-ribosomal RNAs—circRNAs hold immense potential as biomarkers and therapeutic agents for conditions like cancer, cardiovascular diseases, and Alzheimer’s.
Challenges and Advances in circRNA Research
CircRNAs are notoriously tricky to study because their circular structure makes them nearly indistinguishable from linear RNAs produced from the same genomic regions. Researchers need to specifically identify the “back-splice junctions” that define these molecules. Sequencing, while helpful, requires optimized methods to exclude ribosomal RNA and focus on circular forms. Techniques like RNase R digestion, custom algorithms for junction detection, and synthetic controls (e.g., SynCRS) are helping researchers overcome these hurdles.
What’s Next?
With innovations like synthetic circRNAs and evolving computational tools, the field is poised to uncover groundbreaking insights. As Grace Chen of Yale advises, collaboration with experienced researchers and adherence to best practices are essential for success. These “crazy molecules,” as Rajewsky calls them, could unlock new frontiers in biology and medicine.
Discover sponsorship opportunities on the upcoming Nature Technology features tailored to elevate your presence among leading scientists, researchers, and innovators. Contact us today to learn more.
Reaching our Life & Physical sciences audiences
Take advantage of our life sciences and physical sciences advertising and content solutions to get your message in front of thousands of scientists reading our 1,600 science journals. Discover our scientist audiences >>